Quarterly report pursuant to Section 13 or 15(d)

Investment in Saneron CCEL Therapeutics, Inc. (''Saneron'') (Details)

v2.4.0.6
Investment in Saneron CCEL Therapeutics, Inc. (''Saneron'') (Details) (USD $)
3 Months Ended 12 Months Ended
Feb. 28, 2013
Feb. 29, 2012
Nov. 30, 2012
Investment in Saneron CCEL Therapeutics, Inc. (''Saneron'') (Textual) [Abstract]      
Value of treasury stock $ 2,434,550   $ 2,187,505
Saneron [Member]
     
Investment in Saneron CCEL Therapeutics, Inc. (''Saneron'') (Textual) [Abstract]      
Ownership interest 34.00%   34.00%
Goodwill 684,000   684,000
Goodwill Impairment 0   0
Equity in losses of Saneron operations 38,000 39,000  
Value of treasury stock $ 485,000   $ 485,000